Biotech and Pharmaceuticals

Trump Health Care Plan Expected to Benefit Pharmaceutical Companies

by
Trump Health Care Plan Expected to Benefit Pharmaceutical Companies

Pharmaceutical companies are​ cautiously optimistic about‌ their prospects under ⁤the new‌ Trump management, following four years‌ of stringent ‌policies under former President Joe Biden. President Donald Trump,who has prioritized lowering healthcare costs for ⁢Americans,is ‍expected to take a‍ more business-pleasant approach compared to his predecessor. This shift comes‌ as U.S. patients ⁢continue to‌ pay two-to-three … Read more

Strategas Predicts Health Care Sector to Outperform in 2025

by
Strategas Predicts Health Care Sector to Outperform in 2025

The health care sector is poised for a meaningful rebound in 2024, ⁣according to Strategas analysts, who predict it will ⁤lead the market after years ​of regulatory pressures. Chris Verrone,head of ⁣macro ‍and technical trading at Strategas,notes that the sector is ‌experiencing a “generational oversold condition,” with‍ it’s weight in the ⁢S&P 500 at its … Read more

FDA Approves Johnson & Johnson’s Spravato Nasal Spray for Depression Treatment

by
FDA Approves Johnson & Johnson’s Spravato Nasal Spray for Depression Treatment

FDA Approves Johnson & Johnson’s‌ Spravato ⁣as frist Standalone Therapy ‍for Treatment-Resistant Depression ‌ In‍ a groundbreaking move, ​the Food‌ and Drug Administration (FDA) has ⁣approved Johnson &⁣ Johnson’s nasal ⁤spray, Spravato, as⁣ the first-ever standalone therapy for adults with treatment-resistant depression. This decision marks⁤ a meaningful milestone in mental health treatment, offering new ⁤hope … Read more

Medicare $2,000 Prescription Drug Cap Could Save Enrollees Thousands, Reports AARP

by
Medicare ,000 Prescription Drug Cap Could Save Enrollees Thousands, Reports AARP

Medicare’s⁤ $2,000 Prescription Drug Cap: ⁣A Lifeline for Millions in 2025 For millions of older Americans,the ⁢new $2,000 cap on out-of-pocket prescription drug costs under ‌Medicare Part D is more than just a policy change—it’s‍ a financial lifeline. According to a report released ​by AARP, this cap, which took effect at the start of 2025, … Read more

Eli Lilly and Amazon Unveil Strategic Deals at JPMorgan Conference

by
Eli Lilly and Amazon Unveil Strategic Deals at JPMorgan Conference

The annual JPMorgan Health Care Conference, held at the Westin St.Francis Hotel in San‍ Francisco,has ⁢once again become the epicenter of discussions shaping ​the future of the health-care industry. As the largest gathering ⁢of biotech⁣ and pharma executives, investors, and analysts in the U.S.,the event serves as a barometer for what lies⁤ ahead in 2025.This … Read more

Medicare Now Covers Eli Lilly’s Zepbound for Sleep Apnea, Announces Health Department Agency

by
Medicare Now Covers Eli Lilly’s Zepbound for Sleep Apnea, Announces Health Department Agency

Medicare Coverage for Zepbound: what you Need too Know ⁤ Table of Contents Medicare Coverage for Zepbound: what you Need too Know ⁤ What ⁣is Zepbound? ⁤ Medicare Coverage for Zepbound: The New Rules Key Points ​to Remember: How Does⁣ Zepbound⁢ Compare to Other Weight Loss Drugs? What This ⁣Means for Medicare Beneficiaries Final Thoughts … Read more